Virax Biolabs Group logo

Virax Biolabs Group Share Price Today

(NASDAQ: VRAX)

Virax Biolabs Group share price is $1.36 & ₹118.28 as on 6 Mar 2025, 2.30 'hrs' IST

$1.36

-0.11

(-7.48%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Virax Biolabs Group share price in Dollar and Rupees. Guide to invest in Virax Biolabs Group stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Virax Biolabs Group, along with analyst recommendations, forecasts, and comprehensive financials.

Virax Biolabs Group share price movements

  • Today's Low: $1.36
    Today's High: $1.50

    Day's Volatility :9.33%

  • 52 Weeks Low: $0.60
    52 Weeks High: $9.00

    52 Weeks Volatility :93.33%

Virax Biolabs Group (VRAX) Returns

PeriodVirax Biolabs Group LtdIndex (Russel 2000)
3 Months
-20.47%
0.0%
6 Months
-66.25%
0.0%
1 Year
38.78%
0.0%
3 Years
-99.25%
-11.6%

Virax Biolabs Group (VRAX) Key Statistics

in dollars & INR

Previous Close
$1.47
Open
$1.47
Today's High
$1.5
Today's Low
$1.36
Market Capitalization
$5.9M
Today's Volume
$215.9K
52 Week High
$8.9999
52 Week Low
$0.6
Revenue TTM
$84.9K
EBITDA
$-6.1M
Earnings Per Share (EPS)
$-2.61
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-90.64%

How to invest in Virax Biolabs Group Stock (VRAX) from India?

It is very easy for Indian residents to invest directly in Virax Biolabs Group from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Virax Biolabs Group stock in both Indian Rupees (INR) and US Dollars (USD). Search for Virax Biolabs Group or VRAX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Virax Biolabs Group or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Virax Biolabs Group shares which would translate to 0.639 fractional shares of Virax Biolabs Group as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Virax Biolabs Group, in just a few clicks!

Returns in Virax Biolabs Group (VRAX) for Indian investors in Rupees

The Virax Biolabs Group stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Virax Biolabs Group investment value today

Current value as on today

₹1,43,724

Returns

₹43,724

(+43.72%)

Returns from Virax Biolabs Group Stock

₹38,776 (+38.78%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Virax Biolabs Group (VRAX)

-40%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Virax Biolabs Group Stock from India on INDmoney has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Virax Biolabs Group

  • UBS Group AG

    0.87%

  • XTX Topco Ltd

    0.27%

  • Royal Bank of Canada

    0.24%

  • R Squared Ltd

    0.06%

Analyst Recommendation on Virax Biolabs Group

Analyst Forecast on Virax Biolabs Group Stock (VRAX)

What analysts predicted

Upside of 1370.59%

Target:

$20.00

Current:

$1.36

Insights on Virax Biolabs Group Stock (Ticker Symbol: VRAX)

  • Price Movement

    In the last 7 days, VRAX stock has moved down by -20.5%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 2.80K → 79.91K (in $), with an average increase of 50.3% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -2.90M → -3.82M (in $), with an average decrease of 31.4% per quarter
  • VRAX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 27.7%
  • Price to Sales

    ForVRAX every $1 of sales, investors are willing to pay $42.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Virax Biolabs Group Technicals Summary

Sell

Neutral

Buy

Virax Biolabs Group is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Virax Biolabs Group (VRAX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Virax Biolabs Group Ltd logo
-18.56%
-66.25%
38.78%
-99.25%
-99.25%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Virax Biolabs Group Ltd logo
NA
NA
NA
0.0
-0.91
-0.48
NA
1.99
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Virax Biolabs Group Ltd logo
NA
$5.9M
-99.25%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Virax Biolabs Group

Virax Biolabs Group Limited, a biotechnology company, distributes, markets, and sells diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name. It also develops T-Cell IVD test kit for COVID-19, which intend to adapt for immunological profiling against multiple viral threats under the ViraxImmune Brand, as well as a proprietary mobile application for ViraxImmune that presents an individual's immunological profiling data and provide advice on the users' immune system. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, pharmaceutical companies, research institutions, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was founded in 2013 and is headquartered in Lanarkshire, the United Kingdom.
Organization
Virax Biolabs Group
Employees
17
CEO
Mr. James Foster
Industry
Miscellaneous

Management People of Virax Biolabs Group

NameTitle
Mr. James Foster
Chairman & CEO
Mr. Jason D. Davis
Chief Financial Officer
Dr. Nigel McCracken M.Sc., Ph.D.
COO & Director
Ms. Joel Yeung
Accounting Manager
Mr. Clement Monteil
Head of Scientific Research & Development
Ms. Lily Fu
Head of Supply Chain

Important FAQs about investing in VRAX Stock from India :

What is Virax Biolabs Group share price today?

Virax Biolabs Group share price today stands at $1.36, Open: $1.47 ; Previous Close: $1.47 ; High: $1.50 ; Low: $1.36 ; 52 Week High: $9.00 ; 52 Week Low: $0.60.

The stock opens at $1.47, after a previous close of $1.47. The stock reached a daily high of $1.50 and a low of $1.36, with a 52-week high of $9.00 and a 52-week low of $0.60.

Can Indians buy Virax Biolabs Group shares?

Yes, Indians can invest in the Virax Biolabs Group (VRAX) from India.

With INDmoney, you can buy Virax Biolabs Group at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Virax Biolabs Group at zero transaction cost.

How can I buy Virax Biolabs Group shares from India?

It is very easy to buy Virax Biolabs Group from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Virax Biolabs Group (VRAX) be purchased?

Yes, you can buy fractional shares of Virax Biolabs Group with INDmoney app.

What are the documents required to start investing in Virax Biolabs Group stocks?

To start investing in Virax Biolabs Group, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Virax Biolabs Group Stock (VRAX)?

Today’s highest price of Virax Biolabs Group (VRAX) is $1.50.

Today’s lowest price of Virax Biolabs Group (VRAX) is $1.36.

What is today's market capitalisation of Virax Biolabs Group?

Today's market capitalisation of Virax Biolabs Group VRAX is 5.9M

What is the 52 Week High and Low Range of Virax Biolabs Group Stock (VRAX)?

  • 52 Week High

    $9.00

  • 52 Week Low

    $0.60

What are the historical returns of Virax Biolabs Group (VRAX)?

  • 1 Month Returns

    -18.56%

  • 3 Months Returns

    -66.25%

  • 1 Year Returns

    38.78%

  • 5 Years Returns

    -99.25%

Who is the Chief Executive Officer (CEO) of Virax Biolabs Group ?

Mr. James Foster is the current Chief Executive Officer (CEO) of Virax Biolabs Group.